Daniel de Boer
Founder at PROQR THERAPEUTICS N.V.
Net worth: 1 M $ as of 2024-04-29
Daniel de Boer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PROQR THERAPEUTICS N.V. | Director/Board Member | - | - |
| Chief Executive Officer | 2012-02-20 | - | |
| Founder | 2012-02-20 | - | |
| Investor Relations Contact | 2012-02-20 | - |
Career history of Daniel de Boer
Former positions of Daniel de Boer
| Companies | Position | Start | End |
|---|---|---|---|
| Running It | Chief Executive Officer | 2004-12-31 | 2011-08-31 |
| Founder | 2004-12-31 | 2011-08-31 | |
| PC Basic B.V. | Chief Executive Officer | 2006-01-31 | 2008-01-31 |
| Founder | 2006-01-31 | 2008-01-31 | |
Amylon Therapeutics BV
 Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Founder | - | - |
Statistics
International
| Netherlands | 5 |
Operational
| Founder | 4 |
| Chief Executive Officer | 3 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PROQR THERAPEUTICS N.V. | Health Technology |
| Private companies | 3 |
|---|---|
| PC Basic B.V. | |
| Running It | |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Daniel de Boer
- Experience
